Fund HoldingsDecheng Capital LLC

Total Portfolio Value
$326.32M
Total Bought
$57.97M
Total Sold
$346.37M
Net Transaction
-$288.40M
Filing Period:
Securities
SharesValue ($K)
Q1 2024
Q2 2024
Change
Q1 2024
Q2 2024
Weight (%)
Change
Nuvation Bio Inc.(NUVB)06,950,239+6,950,239020,2956.22%+20,295
NEWAMSTERDAM PHARMA CO NV
ORDINARY SHARES
0400,000+400,00007,6842.35%+7,684
MERUS NV101,798179,098+77,3004,58410,5973.25%+6,013
VERA THERAPEUTICS INC(VERA)069,767+69,76702,5240.77%+2,524
GeneDx Holdings Corp.(WGS)103,604103,60409462,7080.83%+1,762
KRYSTAL BIOTECH INC(KRYS)65,77265,772011,70312,0783.70%+376
GRAIL INC(GRAL)018,127+18,12702790.09%+279
Nuvation Bio Inc.(NUVB)0646,057+646,05701030.03%+103
ARCELLX INC
COMMON STOCK
01,177+1,1770650.02%+65
Aura Biosciences, Inc.515,555515,55504,0473,8981.19%-150
AtriCure Inc.(ATRC)26,79726,79708156100.19%-205
PHATHOM PHARMACEUTICALS INC(PHAT)850,000850,00009,0278,7552.68%-272
Pyxis Oncology, Inc (formerly Apexigen)326,810326,81001,3921,0820.33%-310
CRINETICS PHARMACEUTICALS IN(CRNX)157,958157,95807,3947,0752.17%-319
LEGEND BIOTECH CORP-ADR(LEGN)86,36398,558+12,1954,8444,3651.34%-479
MOONLAKE IMMUNOTHERAPEUTICS166,600166,60008,3687,3252.24%-1,043
Aadi Bioscience, Inc.526,3290-526,3291,2320-1,232
CYTOKINETICS INC(CYTK)94,04394,04306,5935,0951.56%-1,498
Cue Health Inc.8,980,9090-8,980,9091,6970-1,697
Arcus Biosciences, Inc(RCUS)869,790869,790016,42213,2474.06%-3,175
4D MOLECULAR THERAPEUTICS IN347,835347,835011,0827,3012.24%-3,781
BeyondSpring Inc.4,958,1434,958,143017,70111,9003.65%-5,801
Illumnia, Inc.(ILMN)129,067108,767-20,30017,72311,3533.48%-6,370
Equillium Inc.4,447,3084,447,308010,2733,0830.94%-7,190
10x Genomics, Inc.(TXG)195,8350-195,8357,3500-7,350
Zentalis Pharmaceuticals Inc.2,099,5833,070,442+970,85933,08912,5583.85%-20,531
CG ONCOLOGY INC(CGON)5,458,8105,458,8100239,642172,33552.81%-67,307
Alpine Immune Sciences, Inc.8,317,9240-8,317,924329,7230-329,723
Page 1 of 1